Insights

New CEO Appointment BenevolentAI recently appointed Joerg Moeller as the new CEO, bringing in fresh leadership and potentially opening avenues for new collaborations and partnerships under his guidance.

Strategic Business Update The strategic update to business priorities by BenevolentAI implies a focused approach that aligns with potential sales opportunities likely to yield high returns for shareholders, presenting an optimal time for business collaborations.

Partnership with Merck The recent partnership between BenevolentAI and Merck signifies a willingness to collaborate with industry giants, indicating a proactive approach towards expanding market reach and exploring new business avenues.

US Office Closure BenevolentAI's recent decision to close its US office presents an opportunity to reallocate resources and refocus efforts in other regions, potentially paving the way for new business strategies and market penetration initiatives.

Advanced AI Capabilities With advanced AI tools and a platform that integrates AI and science for drug discovery, BenevolentAI is well-equipped to offer innovative solutions to potential clients, positioning the company as a strong contender in the biotechnology research sector.

BenevolentAI Tech Stack

BenevolentAI uses 8 technology products and services including Google Analytics, Kubernetes, MongoDB, and more. Explore BenevolentAI's tech stack below.

  • Google Analytics
    Analytics
  • Kubernetes
    Containerization
  • MongoDB
    Database
  • Google
    Miscellaneous
  • Qualys
    Network Security
  • Level 5
    Page Builders
  • Microsoft Azure
    Platform As A Service
  • Hadoop
    Programming Languages

Media & News

BenevolentAI's Email Address Formats

BenevolentAI uses at least 2 format(s):
BenevolentAI Email FormatsExamplePercentage
first.last@benevolent.aiJohn.Doe@benevolent.ai
95%
first.middle@benevolent.aiJohn.Michael@benevolent.ai
2%
first.middle.last@benevolent.aiJohn.Michael.Doe@benevolent.ai
2%
first@benevolent.aiJohn@benevolent.ai
0%
firstlast@benevolent.aiJohnDoe@benevolent.ai
1%
first.middlelast@benevolent.aiJohn.MichaelDoe@benevolent.ai
0%
first.last@benevolent.comJohn.Doe@benevolent.com
73%
first@benevolent.comJohn@benevolent.com
23%
firstlast@benevolent.comJohnDoe@benevolent.com
3%
first.middlelast@benevolent.comJohn.MichaelDoe@benevolent.com
1%

Frequently Asked Questions

Where is BenevolentAI's headquarters located?

Minus sign iconPlus sign icon
BenevolentAI's main headquarters is located at Maple Street 4-8 London, Greater London W1T 5HD GB. The company has employees across 5 continents, including EuropeNorth AmericaOceania.

What is BenevolentAI's official website and social media links?

Minus sign iconPlus sign icon
BenevolentAI's official website is benevolent.com and has social profiles on LinkedIn.

How much revenue does BenevolentAI generate?

Minus sign iconPlus sign icon
As of June 2024, BenevolentAI's annual revenue reached $75M.

What is BenevolentAI's SIC code NAICS code?

Minus sign iconPlus sign icon
BenevolentAI's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BenevolentAI have currently?

Minus sign iconPlus sign icon
As of June 2024, BenevolentAI has approximately 263 employees across 5 continents, including EuropeNorth AmericaOceania. Key team members include Chief Executive Officer: B. S.Chief People Officer: A. F.Chief Revenue Officer Cro: C. B.. Explore BenevolentAI's employee directory with LeadIQ.

What industry does BenevolentAI belong to?

Minus sign iconPlus sign icon
BenevolentAI operates in the Biotechnology Research industry.

What technology does BenevolentAI use?

Minus sign iconPlus sign icon
BenevolentAI's tech stack includes Google AnalyticsKubernetesMongoDBGoogleQualysLevel 5Microsoft AzureHadoop.

What is BenevolentAI's email format?

Minus sign iconPlus sign icon
BenevolentAI's email format typically follows the pattern of . Find more BenevolentAI email formats with LeadIQ.

How much funding has BenevolentAI raised to date?

Minus sign iconPlus sign icon
As of June 2024, BenevolentAI has raised $90M in funding. The last funding round occurred on Sep 17, 2019.

When was BenevolentAI founded?

Minus sign iconPlus sign icon
BenevolentAI was founded in 2013.
BenevolentAI

BenevolentAI

Biotechnology ResearchGreater London, United Kingdom201-500 Employees

BenevevolentAI is a global pioneer and leader in AI-augmented drug discovery. We serve patients by leveraging our proprietary and validated Benevolent Platform that integrates AI and science to uncover new biology, predict novel targets and develop first-in-class or best-in-class drugs for complex diseases. 
By applying proprietary advanced AI tools, in combination with in-house scientific expertise and wet-lab facilities, Benevolent is well-positioned to identify and accelerate novel drug discoveries. 

Section iconCompany Overview

Headquarters
Maple Street 4-8 London, Greater London W1T 5HD GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $90M

    BenevolentAI has raised a total of $90M of funding over 3 rounds. Their latest funding round was raised on Sep 17, 2019.

  • $50M$100M

    BenevolentAI's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $90M

    BenevolentAI has raised a total of $90M of funding over 3 rounds. Their latest funding round was raised on Sep 17, 2019.

  • $50M$100M

    BenevolentAI's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.